ibogaine has been researched along with veratridine in 2 studies
| Studies (ibogaine) | Trials (ibogaine) | Recent Studies (post-2010) (ibogaine) | Studies (veratridine) | Trials (veratridine) | Recent Studies (post-2010) (veratridine) |
|---|---|---|---|---|---|
| 445 | 8 | 136 | 1,755 | 0 | 86 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mah, SJ; Nagel, JE; Schneider, AS | 1 |
| Elisabetsky, E; Emanuelli, T; Leal, MB; Porciúncula, LD; Souza, DO | 1 |
2 other study(ies) available for ibogaine and veratridine
| Article | Year |
|---|---|
Ibogaine selectively inhibits nicotinic receptor-mediated catecholamine release.
Topics: Animals; Catecholamines; Cattle; Chromaffin Cells; Ibogaine; Nicotinic Antagonists; Potassium; Psychotropic Drugs; Receptors, Nicotinic; Veratridine | 1996 |
Ibogaine alters synaptosomal and glial glutamate release and uptake.
Topics: Animals; Astrocytes; Calcium; Cells, Cultured; Cerebral Cortex; Excitatory Amino Acid Antagonists; Glutamic Acid; Ibogaine; Male; Mice; Mice, Inbred Strains; Rats; Rats, Wistar; Synaptosomes; Tetrodotoxin; Tritium; Veratridine | 2001 |